Summary

Overview
The Mexico probiotic food supplement market recorded a value of US$ 55 million in 2024 and is expected to reach a value of US$ 94.30 million in 2028, growing at a CAGR of 14.87% during the forecast period (2025-2028).
The probiotic food supplements market in Mexico is experiencing steady growth, driven by increasing consumer awareness of gut health, rising demand for functional foods and a shift towards preventive healthcare. Responding to this growing demand, companies are investing in research and development, expansion, etc. For instance, in 2022, M8 Pharmaceuticals' Mexican affiliate received COFEPRIS approval for MOKBIO, the first psychobiotic L. plantarum PS128 in Mexico. This innovative probiotic supports neurological and mental health, targeting conditions like anxiety, depression, autism and Parkinson's disease.
Moreover, probiotic supplements, particularly those aimed at supporting digestion and boosting immunity, are becoming a staple in many households. This is evident from the rise in probiotic-based products like kombucha, kefir and probiotic-infused teas, which offer a more natural alternative to traditional supplements. The market is further driven by the growing influence of e-commerce platforms, allowing brands to reach a wider audience and offer convenient purchasing options.
Drivers
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases and obesity in Mexico is significantly driving the demand for probiotic food supplements. Poor dietary habits, sedentary lifestyles and genetic predispositions have contributed to the widespread occurrence of these chronic conditions, leading consumers to seek proactive health solutions like probiotics to support overall well-being.
For instance, an article published in the National Library of Medicine, in 2022, stated that diabetes is a leading cause of disability, morbidity and mortality worldwide. In Mexico, diabetes is the second leading cause of death and has an estimated prevalence of 15.2% (12.8 million adults); furthermore, over the past three decades, mortality attributable to diabetes increased by an alarming 77%. Additionally, Mexico has one of the highest obesity rates in the OECD, with nearly four out of ten adults affected. It also leads the world in diabetes, with 16.9% of the population diagnosed.
The rising prevalence of chronic diseases like obesity, diabetes and cardiovascular disorders is driving the demand for probiotic food supplements, as consumers seek solutions to improve digestion, manage weight and enhance overall health. Probiotic supplements are being recognized for their potential to improve metabolic health, reduce inflammation and enhance immune function, making them an essential part of health-conscious consumers' daily routines.
Growth in the Functional Food & Beverage Industry
The rapid expansion of the functional food and beverage industry in Mexico is a key driver of the probiotic food supplements market. As consumers increasingly seek products that offer health benefits beyond basic nutrition, the demand for functional foods and beverages infused with probiotics has surged. This trend is being fueled by growing health consciousness, changing dietary patterns and a preference for convenient, ready-to-consume probiotic solutions that support digestive health and immunity.
To meet increasing consumer demand, companies are forming collaborations and partnerships. For instance, in October 2024, UK-based ProBiotix Health plc partnered with Mexico's Raff to distribute probiotics aimed at supporting cardiometabolic health. The deal strengthens ProBiotix's global reach and addresses rising demand for health-focused ingredients in Latin America.
Restraints
Lack of Awareness and Education
The lack of awareness about probiotic food supplements is a key barrier to market growth in Mexico. Many consumers, especially in rural and semi-urban areas, remain unaware of the health benefits of probiotics, such as improved digestion, immunity and gut health. Probiotics are often perceived as luxury products rather than essential health supplements, leading to low adoption.
In regions like Chiapas and Oaxaca, traditional remedies such as herbal teas and tepache are preferred due to cultural significance and affordability, limiting probiotic market penetration. Additionally, healthcare professionals rarely recommend probiotics as preventive health solutions, reducing consumer trust and interest.
Misinformation and skepticism further restrain growth, with many consumers unsure of the difference between probiotic-rich foods and supplements. For instance, surveys in Mexico City show that while yogurt consumption is common, awareness of probiotic supplements remains low.
Segment Analysis
The Mexico probiotic food supplement market is segmented based on ingredients, dosage, application, age and distribution channel.
Growing Digestive Disorders in Mexico
Gastrointestinal health holds a significant share in the Mexican probiotic supplement market due to the high prevalence of digestive issues and growing consumer awareness about gut health. According to the NCB, in Mexico, waterborne gastrointestinal diseases (WGD) contribute to 1.9% of child mortality among children aged 3 to 15 years.
Probiotics are increasingly recognized as effective in managing conditions like diarrhea, irritable bowel syndrome (IBS) and constipation. Waterborne gastrointestinal diseases, particularly in rural areas, have driven demand for supplements that support gut health. The rising middle class in Mexico is more health-conscious, favoring natural solutions like probiotics for long-term wellness.
Sustainability Analysis
With a growing awareness of gut health and wellness, the Mexican market for probiotics is expanding, presenting opportunities for sustainable development. Sourcing natural, non-GMO and organic ingredients from local suppliers can reduce environmental impact while supporting local agriculture. Packaging innovations, such as biodegradable or recyclable materials, can further enhance sustainability efforts.
However, challenges like high energy consumption in manufacturing, cold chain logistics for live cultures and water usage must be addressed to minimize ecological footprints. Encouraging shorter supply chains and eco-friendly transportation methods can reduce carbon emissions. Educating consumers on proper usage and disposal of supplements promotes responsible consumption. Certifications like USDA Organic or Carbon Neutral can build trust and enhance brand value. Overall, a commitment to sustainability across the lifecycle of probiotic supplements can meet consumer expectations while aligning with environmental and social goals.
Unmet Needs
An unmet need in the Mexico probiotic food supplements market is the lack of affordable and accessible products for consumers in rural and semi-urban areas. While probiotic products are commonly available in urban centers and online platforms, many rural areas, such as Chiapas, Oaxaca and Puebla, face barriers to access due to high product costs and limited retail presence. These regions still rely heavily on traditional remedies and probiotic supplements are often perceived as expensive or unnecessary.
Another significant unmet need is the lack of education and awareness about the health benefits of probiotics, particularly in rural Mexico. Many consumers still believe probiotics are only for specific digestive issues or severe health conditions, not understanding their broader benefits, such as boosting immunity, mental health and skin care.
The demand for lactose-free, plant-based and gluten-free probiotic products is rising, but there remains an unmet need for products that cater to specific dietary restrictions. While plant-based options like almond, coconut and oat milk are gaining popularity, there is still limited availability of probiotic supplements that meet the needs of people with other dietary preferences, such as vegans or those with food allergies.
Another unmet need is the lack of convenient, on-the-go probiotic options that fit into busy lifestyles. While probiotic supplements are available in capsule and powder form, many consumers are seeking more portable formats like gummies, chews or ready-to-drink probiotic beverages that are easy to consume during a hectic day.
Competitive Landscape
The major players in the market include Pavia De Mexico, Omnilife Group, S.A. De C.V., B Life Company, Global Companies, BIOCODEX (Biocodex de México, SA de CV), Amway (Amway de México, S. de R.L. de C.V.), Herbalife International of America, Inc. (Herbalife International Of Mexico, Sa De Cv), BioGaia (BioGaia Mexico), NOW Health Group, Inc.
By Ingredient
• Lactobacillus
• Streptococcus
• Bifidobacterium
• Others
By Dosage
• Tablet
• Capsules
• Liquid
• Powder
• Others
o Chewables & Gummies
o Soft Gels
o Others
By Application
• Gastrointestinal Health
o Gut Microbiota/Microbiome Balance
o Digestion
o Constipation
o Bloating
o Diarrhea
o Leaky Gut
o Inflammation
o Immune System
o Others
 Gluten sensitivity
 Abdominal Pain
 GERD/Helicobacter pylori
 Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment
 Gut Flora/Gut Microbiome Restoration
 Others
• Vaginal Health
• Urinary Tract Health
o Kidney Stones
o UTIs
o Others
• Oral Health
• Anti/Healthy Ageing
• Allergies/Asthma
• Bone & Joint Health
o Osteoarthritis
o Osteoporosis/Low Mineral Bone Density
o Inflammation
• Brain/Mental Health
o Sleep
o Cognition
o Mood
o Depression
o Focus
• Cardiovascular Health
• Circulation
• Energy/Fatigue Reduction
• Metabolic Syndrome/Blood Glucose
• Liver Health
• Energy
• Immunity/Respiratory Infections
• Nutrient Absorption
• Skin-Hair-Nails
o Atopic Dermatitis & Eczema
o Acne
o Rosacea
o Hair Growth/Hair Loss
o Skin Microbiome
o Others
• Sports
• Women’s Health
o Fertility
o Menopause
o Pregnancy
o Pcos
o Vaginal Health & Health Vaginal Microbiome
o Vaginal Infections (Bv/Vvc)
o Pregnancy Outcomes
o Others
• Men’s Health & Men's Fertility
• Weight Management
• Pediatric Health
o Colic
o Constipation
o Regurgitation
o Atopic Dermatitis
o Others
• Others
By Age
• Infant
• Children
• Adults
• Seniors
By Distribution Channels
• Supermarkets/Hypermarkets
• Pharmacies and Drug Stores
• Convenience Stores
• Online Retailers
• Other Distribution Channels
Key Developments
• In October 2024, UK-based ProBiotix Health plc partnered with Mexico's Raff to distribute probiotics aimed at supporting cardiometabolic health. The deal strengthens ProBiotix's global reach and addresses the rising demand for health-focused ingredients in Latin America.
• In May 2022, M8 Pharmaceuticals' Mexican affiliate received COFEPRIS approval for MOKBIO, the first psychobiotic L. plantarum PS128 in Mexico. This innovative probiotic supports neurological and mental health, targeting conditions like anxiety, depression, autism and Parkinson's disease. MOKBIO marks M8's first original product approval in the country.
Why Purchase the Report?
• To visualize the Mexico probiotic food supplement market segmentation based on ingredient, dosage, application, age and distribution channel, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of Mexico probiotic food supplement market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The Mexico probiotic food supplement report would provide approximately 39 tables, 58 figures and 197 pages.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Ingredient
3.2. Snippet by Dosage
3.3. Snippet by Application
3.4. Snippet by Age
3.5. Snippet by Distribution Channel
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Chronic Diseases
4.1.1.2. Growth in the Functional Food & Beverage Industry
4.1.2. Restraints
4.1.2.1. Lack of Awareness and Education
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. By Ingredient
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
6.1.2. Market Attractiveness Index, By Ingredient
6.2. Lactobacillus*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Streptococcus
6.4. Bifidobacterium
6.5. Others
7. By Dosage
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
7.1.2. Market Attractiveness Index, By Dosage
7.2. Tablet*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Capsules
7.4. Liquid
7.5. Powder
7.6. Others
7.6.1. Chewables & Gummies
7.6.2. Soft Gels
7.6.3. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Gastrointestinal Health*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Gut Microbiota/Microbiome Balance
8.2.4. Digestion
8.2.5. Constipation
8.2.6. Bloating
8.2.7. Diarrhea
8.2.8. Leaky Gut
8.2.9. Inflammation
8.2.10. Immune System
8.2.11. Others
8.2.11.1. Gluten sensitivity
8.2.11.2. Abdominal Pain
8.2.11.3. GERD/Helicobacter pylori
8.2.11.4. Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment
8.2.11.5. Gut Flora/Gut Microbiome Restoration
8.2.11.6. Others
8.3. Vaginal Health
8.4. Urinary Tract Health
8.4.1. Kidney Stones
8.4.2. UTIs
8.4.3. Others
8.5. Oral Health
8.6. Anti/Healthy Ageing
8.7. Allergies/Asthma
8.8. Bone & Joint Health
8.8.1. Osteoarthritis
8.8.2. Osteoporosis/Low Mineral Bone Density
8.8.3. Inflammation
8.9. Brain/Mental Health
8.9.1. Sleep
8.9.2. Cognition
8.9.3. Mood
8.9.4. Depression
8.9.5. Focus
8.10. Cardiovascular Health
8.11. Circulation
8.12. Energy/Fatigue Reduction
8.13. Metabolic Syndrome/Blood Glucose
8.14. Liver Health
8.15. Energy
8.16. Immunity/Respiratory Infections
8.17. Nutrient Absorption
8.18. Skin-Hair-Nails
8.18.1. Atopic Dermatitis & Eczema
8.18.2. Acne
8.18.3. Rosacea
8.18.4. Hair Growth/Hair Loss
8.18.5. Skin Microbiome
8.18.6. Others
8.19. Sports
8.20. Women’s Health
8.20.1. Fertility
8.20.2. Menopause
8.20.3. Pregnancy
8.20.4. Pcos
8.20.5. Vaginal Health & Health Vaginal Microbiome
8.20.6. Vaginal Infections (Bv/Vvc)
8.20.7. Pregnancy Outcomes
8.20.8. Others
8.21. Men’s Health & Men's Fertility
8.22. Weight Management
8.23. Pediatric Health
8.23.1. Colic
8.23.2. Constipation
8.23.3. Regurgitation
8.23.4. Atopic Dermatitis
8.23.5. Others
8.24. Others
9. By Age
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
9.1.2. Market Attractiveness Index, By Age
9.2. Infant*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Children
9.4. Adults
9.5. Seniors
10. By Distribution Channel
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Supermarkets/Hypermarkets*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Pharmacies and Drug Stores
10.4. Convenience Stores
10.5. Online Retailers
10.6. Other Distribution Channels
11. Sustainability Analysis
11.1. Environmental Analysis
11.2. Economic Analysis
11.3. Governance Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Pavia De Mexico*
13.1.1. Company Overview
13.1.2. Type Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Omnilife Group, S.A. De C.V.
13.3. B Life Company
13.4. BIOCODEX (Biocodex de México, SA de CV)
13.5. Amway (Amway de México, S. de R.L. de C.V.)
13.6. Herbalife International of America, Inc. (Herbalife International Of Mexico, Sa De Cv)
13.7. BioGaia (BioGaia Mexico)
13.8. NOW Health Group, Inc.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us